Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumathi Nambiar

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Drug Safety|May 23, 2012
Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reportsPeter W Kim, Alfred F Sorbello, Ronald T Wassel, et al.
Emerging Infectious Diseases|October 19, 2005
Characterizing vancomycin-resistant enterococci in neonatal intensive careC Rebecca Sherer, Bruce M Sprague, Joseph M Campos, et al.
Clinical Pharmacology and Therapeutics|July 6, 2022
Cefiderocol Dosing for Patients Receiving Continuous Renal Replacement TherapyXiaohui Wei, Shabnam Naseer, Edward A Weinstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2010
Meta-analysis of a possible signal of increased mortality associated with cefepime usePeter W Kim, Yu-te Wu, Charles Cooper, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Facilitators and barriers to the successful implementation of pediatric antibacterial drug trials: Findings from CTTI's survey of investigatorsAmy Corneli, Chris Wheeler, John Bradley, et al.
Proceedings (Baylor University. Medical Center)|June 24, 2024
Clinical fellowship augmented by regulatory review experience: a perspective on the Children's National Hospital/FDA fellowship tracksJency Daniel, Nicholas Geagan, Nada Harik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2021
US Food and Drug Administration (FDA): Benefit-Risk Considerations for Cefiderocol (Fetroja®)Shabnam Naseer, Edward A Weinstein, Daniel B Rubin, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Parents' perceived obstacles to pediatric clinical trial participation: Findings from the clinical trials transformation initiativeRachel G Greenberg, Breck Gamel, Diane Bloom, et al.
Bulletin of the World Health Organization|December 5, 2022
Antibiotics needed to treat multidrug-resistant infections in neonatesPhoebe Cm Williams, Shamim A Qazi, Ramesh Agarwal, et al.
Pediatrics|August 31, 2018
Pediatric Antibacterial and Antifungal Trials From 2007 to 2017Joshua T Thaden, Karen Chiswell, Ian Jaffe, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Drug Safety|May 23, 2012
Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reportsPeter W Kim, Alfred F Sorbello, Ronald T Wassel, et al.
Emerging Infectious Diseases|October 19, 2005
Characterizing vancomycin-resistant enterococci in neonatal intensive careC Rebecca Sherer, Bruce M Sprague, Joseph M Campos, et al.
Clinical Pharmacology and Therapeutics|July 6, 2022
Cefiderocol Dosing for Patients Receiving Continuous Renal Replacement TherapyXiaohui Wei, Shabnam Naseer, Edward A Weinstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2010
Meta-analysis of a possible signal of increased mortality associated with cefepime usePeter W Kim, Yu-te Wu, Charles Cooper, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Facilitators and barriers to the successful implementation of pediatric antibacterial drug trials: Findings from CTTI's survey of investigatorsAmy Corneli, Chris Wheeler, John Bradley, et al.
Proceedings (Baylor University. Medical Center)|June 24, 2024
Clinical fellowship augmented by regulatory review experience: a perspective on the Children's National Hospital/FDA fellowship tracksJency Daniel, Nicholas Geagan, Nada Harik, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2021
US Food and Drug Administration (FDA): Benefit-Risk Considerations for Cefiderocol (Fetroja®)Shabnam Naseer, Edward A Weinstein, Daniel B Rubin, et al.
Contemporary Clinical Trials Communications|April 27, 2018
Parents' perceived obstacles to pediatric clinical trial participation: Findings from the clinical trials transformation initiativeRachel G Greenberg, Breck Gamel, Diane Bloom, et al.
Bulletin of the World Health Organization|December 5, 2022
Antibiotics needed to treat multidrug-resistant infections in neonatesPhoebe Cm Williams, Shamim A Qazi, Ramesh Agarwal, et al.
Pediatrics|August 31, 2018
Pediatric Antibacterial and Antifungal Trials From 2007 to 2017Joshua T Thaden, Karen Chiswell, Ian Jaffe, et al.
Pageof 5